It mimics the naturally occurring GLP-1 hormone, which helps regulate blood sugar levels and appetite
The current Cancer Council Australia and Melanoma Institute Australia (2022) Clinical Guidelines make the following recommendations for follow-up for patients with invasive melanoma: Skin self-examination and sun-smart behaviour education Routine skin checks by the patient's preferred health professional Follow-up intervals: Stage I: follow-up annually for 10 years Stage IIA: every 6 months for 2 years, then annually for 8 years Stage IIB and IIC: every 3 to 4 months for 2 years, every 6 months during year 3, then annually for 5 years
Sources Asano, D., Takakusa, H., & Nakai, D
These reactions may be related to changes in appetite, food intake, digestion, hydration, and gastrointestinal signaling
Expect warmth: Many users report feeling warmer than usual, especially in the early weeks of treatment